Helios shares have climbed 25.5% over the past six months to $80.44, outperforming the S&P 500 by 16.8 percentage points, yet analysts caution that the stock may underperform due to weak organic growth, shrinking margins, and declining returns on invested capital. Organic revenue growth averaged just 3.3% annually over the last two years, signaling sluggish demand in its core business. Operating margin contracted by 8.4 percentage points over five years to 9% on a trailing 12-month basis, raising concerns about expense management despite revenue gains. Return on invested capital has also trended lower, suggesting limited profitable reinvestment opportunities. At a forward price-to-earnings ratio of 27.1 times, the stock appears to price in significant optimism, leading analysts to recommend looking elsewhere for better fundamentals.
Helios Technologies IncWeak organic growth of 3.3% annually signals sluggish demand in core business.